Physician profile
Tedros Andom
NPI 1629160262
$137,332.48
in general payments reported to CMS, 2019-2025
25 companies · $4,772 in 2025
The $4,772 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $5,379 · 2021: $20K · 2022: $14K · 2023: $20K · 2024: $40K · 2025: $4,772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $55K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Food and Beverage: $3,999 · Travel and Lodging: $1,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $55,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Food and Beverage | $3,999.09 |
| Travel and Lodging | $1,437.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $134,664.54 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $1,458.34 | 2021-2023 | Phasix Mesh |
| Medtronic, INC. | $215.50 | 2023 | Interstim, Signia, Sonicision |
| Ethicon US, LLC | $196.78 | 2019-2025 | Proximate, Echelon Endopath, Harmonic |
| Smith+Nephew, INC. | $162.86 | 2021-2025 | Collagenase Santyl, Grafix Pl |
| Becton, Dickinson and Company | $130.99 | 2019 | |
| Molli Surgical (US) INC | $79.15 | 2023 | |
| Conmed Corporation | $53.22 | 2022 | |
| Novo Nordisk INC | $47.04 | 2019-2025 | Wegovy |
| Daiichi Sankyo INC. | $41.18 | 2019-2021 | |
| Lilly USA, LLC | $35.19 | 2025 | Zepbound, Mounjaro |
| Vertex Pharmaceuticals Incorporated | $30.28 | 2025 | |
| Currax Pharmaceuticals LLC | $28.41 | 2022 | |
| Olympus America INC. | $24.39 | 2021 | |
| Csl Behring | $21.34 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $20.99 | 2025 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Allergan, INC. | $17.55 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.48 | 2023 | Gattex |
| Integra Lifesciences Corporation | $15.16 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Merck Sharp & Dohme LLC | $15.10 | 2019 | |
| W. L. Gore & Associates, INC. | $15.05 | 2021 | |
| Wound Management Technologies, INC | $14.29 | 2019 | |
| Eisai INC. | $12.24 | 2019 | |
| Celularity INC. | $12.00 | 2019 | |
| Z-Medica, LLC | $4.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tedros Andom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.